1. Home
  2. ABR vs ANIP Comparison

ABR vs ANIP Comparison

Compare ABR & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABR
  • ANIP
  • Stock Information
  • Founded
  • ABR 2003
  • ANIP 2001
  • Country
  • ABR United States
  • ANIP United States
  • Employees
  • ABR N/A
  • ANIP N/A
  • Industry
  • ABR Real Estate Investment Trusts
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • ABR Real Estate
  • ANIP Health Care
  • Exchange
  • ABR Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • ABR 2.3B
  • ANIP 2.0B
  • IPO Year
  • ABR 2004
  • ANIP N/A
  • Fundamental
  • Price
  • ABR $11.75
  • ANIP $93.29
  • Analyst Decision
  • ABR Hold
  • ANIP Strong Buy
  • Analyst Count
  • ABR 6
  • ANIP 7
  • Target Price
  • ABR $12.30
  • ANIP $99.14
  • AVG Volume (30 Days)
  • ABR 2.0M
  • ANIP 343.4K
  • Earning Date
  • ABR 10-31-2025
  • ANIP 11-07-2025
  • Dividend Yield
  • ABR 10.21%
  • ANIP N/A
  • EPS Growth
  • ABR N/A
  • ANIP N/A
  • EPS
  • ABR 0.91
  • ANIP N/A
  • Revenue
  • ABR $600,587,000.00
  • ANIP $747,399,000.00
  • Revenue This Year
  • ABR N/A
  • ANIP $39.99
  • Revenue Next Year
  • ABR $5.18
  • ANIP $9.57
  • P/E Ratio
  • ABR $12.98
  • ANIP N/A
  • Revenue Growth
  • ABR N/A
  • ANIP 38.68
  • 52 Week Low
  • ABR $8.43
  • ANIP $52.50
  • 52 Week High
  • ABR $15.76
  • ANIP $99.50
  • Technical
  • Relative Strength Index (RSI)
  • ABR 47.47
  • ANIP 52.75
  • Support Level
  • ABR $11.65
  • ANIP $93.00
  • Resistance Level
  • ABR $11.95
  • ANIP $96.99
  • Average True Range (ATR)
  • ABR 0.30
  • ANIP 2.81
  • MACD
  • ABR -0.01
  • ANIP 0.14
  • Stochastic Oscillator
  • ABR 50.00
  • ANIP 60.60

About ABR Arbor Realty Trust

Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment. The company is externally managed and advised by Arbor Commercial Mortgage, LLC.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: